LSL Pharma Group (TSXV:LSL) FCF Margin % : -12.17% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. LSL Pharma Group's Free Cash Flow for the three months ended in Dec. 2023 was C$-0.42 Mil. LSL Pharma Group's Revenue for the three months ended in Dec. 2023 was C$3.46 Mil. Therefore, LSL Pharma Group's FCF Margin % for the quarter that ended in Dec. 2023 was -12.17%.

As of today, LSL Pharma Group's current FCF Yield % is -14.98%.

The historical rank and industry rank for LSL Pharma Group's FCF Margin % or its related term are showing as below:

TSXV:LSL' s FCF Margin % Range Over the Past 10 Years
Min: -80.64 Med: -36.73 Max: -4.23
Current: -80.64

During the past 4 years, the highest FCF Margin % of LSL Pharma Group was -4.23%. The lowest was -80.64%. And the median was -36.73%.

TSXV:LSL's FCF Margin % is ranked worse than
88.81% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.06 vs TSXV:LSL: -80.64

LSL Pharma Group FCF Margin % Historical Data

The historical data trend for LSL Pharma Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group FCF Margin % Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

FCF Margin %

-4.23

-22.80

-50.66

-80.64

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial							-83.76	-236.66	-9.34	-106.93	-12.17

Competitive Comparison of LSL Pharma Group's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LSL Pharma Group's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's FCF Margin % falls into.

LSL Pharma Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

LSL Pharma Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-8.087	/	10.028
	=	-80.64 %

LSL Pharma Group's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.421	/	3.458
	=	-12.17 %

LSL Pharma Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group (TSXV:LSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5

Website

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines